European Archives - Page 1072 of 1303 - European Medical Journal

P-Wave Dispersion and its Association with Hypertension

Hypertension and obesity in adults have been associated with increased P-wave dispersion (PwD). This is postulated due to the correlation of hypertension…

Arrhythmogenic Cardiomyopathy: Genetic Pathology, Inflammatory Syndrome, or both?

Arrhythmogenic cardiomyopathy (ACM) affects mainly young athletes <35 years old and has a potential risk of malignant arrhythmias and sudden death.

Cardiac Cachexia Syndrome

This review gathers evidence to enable recognition of cardiac cachexia and improve identification of patients with terminal heart failure.

EMJ Cardiology 5.1 2017

Inside, you will find copious amounts of exciting, new research, including some fantastic highlights from this year’s ESC…

RedHill Biopharma Announces Positive Top-Line Results from Phase II Study of BEKINDA® in Patients with Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Tel-Aviv, Israel/Raleigh, NC, USA, 03 October, 2017 – RedHill Biopharma Ltd. (NASDAQ: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“Red Hill” or the “Company”)…

Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

The Series E funding was supported by existing investors including dievini Hopp Biotech holding, Wellington Partners, AT Impf GmbH and others.

Regulatory Approval in Europe Granted for Synthon’s Glatiramer Acetate 40 mg/ml

Nijmegen, the Netherlands, 05 October, 2017 – Synthon today announced that it has successfully concluded the decentralized procedures for…

CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Testing

Sydney, Australia, 10 October, 2017 – Atomo Diagnostics, a world leader in innovative point-of-care, rapid diagnostic devices, announced today that…

Fire Ant Venom: A New Compound Discovered for Psoriasis Treatment

NTRIGUING new research has found that specific compounds present in fire ant venom have the potential to form a new, topical treatment for psoriasis…

Advanced Stage III Melanoma: Brand New Adjuvant Therapy Discovered

A NOVEL combination of dabrafenib and trametinib has proven a successful adjuvant therapy for Stage III BRAF-mutant melanoma patients, doubling…